Zileuton Extended-Release Tablets, 600 mg, 120-count bottles, Rx only, Distributed by: Prasco Laboratories, Mason, OH 45040 USA; NDC 66993-485-32.
Published June 19, 2019 · Recall initiated: May 31, 2019
Summary
FDA records drug Class II recall D-1342-2019, published June 19, 2019 and initiated May 31, 2019. Recalling firm: Chiesi USA, Inc.; Status: Terminated; Reported quantity: 2598 bottles; Lot: Lots: 3171856, Exp. 12/19. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications: Out of specification result for dissolution.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Chiesi USA, Inc.
- Distributor
- Nationwide in the USA.
- Lot
- Lots: 3171856, Exp. 12/19
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDARevcovi (elapegademase-lvlr) Injection, 2.4mg/1.5mL (1.6 mg/mL), Single-Dose Vial, Rx Only, For IntramuscularSeptember 9, 2026
- FDACLEVIPREX (clevidipine injectable emulsion) 50 mg/100 mL (0.5 mg/mL), 10 Single Use Vials, Rx Only,July 22, 2026
- FDACUROSURF (poractant alfa), 240 mg, Intratracheal Suspension, 3L Single-dose-Vial, Rx only, Chiesi USA, Inc,April 1, 2026
- FDATestosterone Cypionate 200 mg/mL, in a) 5mL vials and b)10 mL vials, Rx only, Pharm D. Solutions 1304 SouthJune 19, 2019
- FDAHeparin Sodium 25,000 USP units per 250 mL (100 USP units per mL) in 5% Dextrose Injection, 250 mL EXCELJune 19, 2019
- FDATestosterone 200 mg/mL, 30 mL vials, Rx only, Pharm D. Solutions 1304 South Loop West, Houston, TX 77054,June 19, 2019
Questions about this recall
Was Zileuton Extended-Release Tablets, 600 mg, 120-count bottles, Rx only, Distributed by: Prasco Laboratories, Mason, OH 45040 USA; NDC 66993-485-32. recalled?
Yes. FDA published recall D-1342-2019 on June 19, 2019. Reported hazard: Failed Dissolution Specifications: Out of specification result for dissolution.
What should I do if I have this product?
Voluntary: Firm initiated · Letter